A single centre, randomised controlled, open label study of rituximab as induction therapy in kidney transplantation. - RituxiCam 2005

Phase 1

• Conditions: Renal Transplantation; MedDRA version: 7.1 Level: PT Classification code 10038533

• Registration Number: EUCTR2005-001496-35-GB
• Lead Sponsor: Cambridge University Hospitals NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-10
• Study Completion: 2008-09-10
• Last Update Posted: 30 June 2019

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

Adult patients undergoing renal transplantation
Are the trial subjects under 18?
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Allergy to mice

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified